
What We're Reading: Idaho, CMS Talk Again; Drug Pricing Poll Answers Vary; Senators Want 340B Info
Idaho is still seeking a way to get its state's health insurance plans approved by CMS; a new poll finds that support for action on drug pricing dips when potential ramifications are weighed; senators seek information on hospitals' use of 340B drug discounts.
Idaho Still Seeking Way to Get State's Health Plan Approved
Idaho insurance head Dean Cameron and Sen. Jim Risch, R-Idaho, met with CMS chief Seema Verma in Washington this week to see if there is still a way around the state’s controversial plan to skirt Affordable Care Act (ACA) rules,
Polls Finds Support for Drug Pricing Action Dips When Ramifications Considered
A POLITICO—Harvard T.H. Chan School of Public Health poll finds bipartisan support for the idea of drastic government action on drug prices. Nine out of 10 favor giving Medicare the power to negotiate directly with pharmaceutical manufacturers, but that support falters when Americans face possible negative trade-offs,
Senators Want Information on Hospitals' Use of 340B Drug Discounts
Senators moved closer to joining the House of Representatives to push hospitals to report how they use 340B drug discounts,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.